Furthermore, given the widespread clinical use of ACE inhibitors, this research may also reveal unintended effects of modulating the renin–angiotensin system on tumor progression, thereby informing safer and more personalized treatment strategies in breast cancer patients [16,31]. This evidence concerns the gene REN and breast carcinoma.